This inventor holds 4 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Anticancer Therapeutic Inventions as, Universitetet I Oslo. Active years: 2003-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mjøndalen, NO (2003)
- Mjondalen, NO (2003 - 2022)
Company Filing History:
Years Active: 2003-2022
Title: Innovator Gjermund Henriksen: Pioneering Advancements in Radionuclide Production
Introduction
Gjermund Henriksen, an accomplished inventor based in Mjondalen, Norway, has made significant contributions to the field of radionuclide production. With a total of four patents to his name, Henriksen's work stands at the intersection of medical technology and innovative chemistry, paving the way for advancements in cancer treatment.
Latest Patents
Among his latest inventions is a groundbreaking patent for a method and apparatus for producing astatine-211 from the alpha-particle bombardment of bismuth-209. This patent outlines a sophisticated process involving the use of a recessed plate designed to hold a bismuth target securely. The apparatus features a cover with an aperture that enables a beam of radiation from a cyclotron to reach the target nuclide, facilitating the production of critical radionuclides. In addition, Henriksen has developed receptor binding conjugates which further enhance the utility of his radionuclide production methods.
Career Highlights
Gjermund Henriksen's career is marked by his innovative work with renowned institutions. He has been associated with Anticancer Therapeutic Inventions and the University of Oslo, contributing his expertise in developing enhanced therapeutic approaches for cancer treatment. His efforts have not only advanced scientific understanding but also aimed at improving patient outcomes in clinical settings.
Collaborations
Throughout his career, Henriksen has collaborated with esteemed colleagues, notably Roy H. Larsen and Øyvind S. Bruland. These collaborations reflect a commitment to research excellence and the sharing of ideas that can drive innovation across the medical and scientific communities.
Conclusion
Gjermund Henriksen exemplifies the spirit of innovation with his specialized focus on radionuclide production. His contributions to the field, embodied in his patents and collaborative efforts, will continue to resonate in the realms of medical research and cancer therapy, inspiring future advancements and discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile